CBIZ Reports Third-Quarter And Nine-Month 2019 Results
THIRD-QUARTER HIGHLIGHTS:
- TOTAL REVENUE +6.9%
- SAME-UNIT REVENUE +5.6%
- EPS FROM CONTINUING OPERATIONS +33.3%
NINE-MONTH HIGHLIGHTS:
- TOTAL REVENUE +3.1%
- SAME-UNIT REVENUE +2.5%
- EPS FROM CONTINUING OPERATIONS +16.2%
For the 2019 third quarter, CBIZ recorded revenue of
For the nine-month period ended
For the nine months ended
Grisko continued, "We completed five acquisitions in the third quarter, and for the year, we have closed a total of six transactions that are expected to add approximately
2019 Full-Year Outlook
- The Company expects growth in total revenue within a range of 3% to 4% over the prior year.
- Although several factors may impact the tax rate, the Company expects an effective tax rate of approximately 25%.
- The Company expects a weighted average fully diluted share count of approximately 55.5 to 56.0 million shares.
- The Company expects to grow fully diluted earnings per share near the high end of a range of 10% to 12% over the
$1.09 reported for 2018.
Conference Call
CBIZ will host a conference call at
A replay of the webcast will be made available approximately two hours following the call on the Company's website at www.cbiz.com. For those without internet access, a replay of the call will also be available starting at approximately
About CBIZ
Forward-Looking Statements
Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the Company's ability to adequately manage and sustain its growth; the Company's dependence on the current trend of outsourcing business services; the Company's dependence on the services of its CEO and other key employees; competitive pricing pressures; general business and economic conditions; and changes in governmental regulation and tax laws affecting the Company's insurance business or its business services operations. A more detailed description of such risks and uncertainties may be found in the Company's filings with the
|
|
||||||||||||||||
|
FINANCIAL HIGHLIGHTS (UNAUDITED) |
||||||||||||||||
|
THREE MONTHS ENDED |
||||||||||||||||
|
(In thousands, except percentages and per share data) |
||||||||||||||||
|
THREE MONTHS ENDED |
||||||||||||||||
|
SEPTEMBER 30, |
||||||||||||||||
|
2019 |
% |
2018 |
% |
|||||||||||||
|
Revenue |
$ |
239,790 |
100.0 |
% |
$ |
224,249 |
100.0 |
% |
||||||||
|
Operating expenses (1) |
209,146 |
87.2 |
% |
198,607 |
88.6 |
% |
||||||||||
|
Gross margin |
30,644 |
12.8 |
% |
25,642 |
11.4 |
% |
||||||||||
|
Corporate general and administrative expenses (1) |
11,670 |
4.9 |
% |
10,279 |
4.5 |
% |
||||||||||
|
Operating income |
18,974 |
7.9 |
% |
15,363 |
6.9 |
% |
||||||||||
|
Other income: |
||||||||||||||||
|
Interest expense |
(1,521) |
-0.6 |
% |
(1,614) |
-0.8 |
% |
||||||||||
|
Loss on sale of operations, net |
(145) |
-0.1 |
% |
- |
0.0 |
% |
||||||||||
|
Other income, net (1) (2) |
6,767 |
2.8 |
% |
3,143 |
1.4 |
% |
||||||||||
|
Total other income, net |
5,101 |
2.1 |
% |
1,529 |
0.6 |
% |
||||||||||
|
Income from continuing operations before income |
24,075 |
10.0 |
% |
16,892 |
7.5 |
% |
||||||||||
|
Income tax expense |
6,069 |
3,297 |
||||||||||||||
|
Income from continuing operations |
18,006 |
7.5 |
% |
13,595 |
6.1 |
% |
||||||||||
|
Loss from operations of discontinued businesses, net of |
(200) |
(9) |
||||||||||||||
|
Net income |
$ |
17,806 |
7.4 |
% |
$ |
13,586 |
6.1 |
% |
||||||||
|
Diluted earnings per share: |
||||||||||||||||
|
Continuing operations |
$ |
0.32 |
$ |
0.24 |
||||||||||||
|
Discontinued operations |
- |
- |
||||||||||||||
|
Net income |
$ |
0.32 |
$ |
0.24 |
||||||||||||
|
Diluted weighted average common shares outstanding |
55,816 |
56,740 |
||||||||||||||
|
Other data from continuing operations: |
||||||||||||||||
|
Adjusted EBITDA (3) |
$ |
31,375 |
$ |
24,358 |
||||||||||||
|
(1) |
CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" ( |
|
(2) |
Included in "Other income, net" for the three months ended |
|
(3) |
Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the nearest generally accepted accounting principles ("GAAP") financial measure, and for additional information as to the usefulness of the Non-GAAP financial measures to shareholders and investors. |
|
|
||||||||||||||||
|
FINANCIAL HIGHLIGHTS (UNAUDITED) |
||||||||||||||||
|
NINE MONTHS ENDED |
||||||||||||||||
|
(In thousands, except percentages and per share data) |
||||||||||||||||
|
NINE MONTHS ENDED |
||||||||||||||||
|
SEPTEMBER 30, |
||||||||||||||||
|
2019 |
% |
2018 |
% |
|||||||||||||
|
Revenue |
$ |
745,286 |
100.0 |
% |
$ |
722,980 |
100.0 |
% |
||||||||
|
Operating expenses (1) |
622,790 |
83.6 |
% |
608,459 |
84.2 |
% |
||||||||||
|
Gross margin |
122,496 |
16.4 |
% |
114,521 |
15.8 |
% |
||||||||||
|
Corporate general and administrative expenses (1) |
33,916 |
4.6 |
% |
30,300 |
4.2 |
% |
||||||||||
|
Operating income |
88,580 |
11.8 |
% |
84,221 |
11.6 |
% |
||||||||||
|
Other income (expense): |
||||||||||||||||
|
Interest expense |
(4,509) |
-0.6 |
% |
(5,211) |
-0.7 |
% |
||||||||||
|
Gain on sale of operations, net |
402 |
0.1 |
% |
663 |
0.1 |
% |
||||||||||
|
Other income, net (1) (2) |
12,716 |
1.7 |
% |
2,544 |
0.4 |
% |
||||||||||
|
Total other income (expense), net |
8,609 |
1.2 |
% |
(2,004) |
-0.2 |
% |
||||||||||
|
Income from continuing operations before income |
97,189 |
13.0 |
% |
82,217 |
11.4 |
% |
||||||||||
|
Income tax expense |
25,004 |
19,691 |
||||||||||||||
|
Income from continuing operations |
72,185 |
9.7 |
% |
62,526 |
8.6 |
% |
||||||||||
|
(Loss) gain from operations of discontinued businesses, |
(318) |
17 |
||||||||||||||
|
Net income |
$ |
71,867 |
9.6 |
% |
$ |
62,543 |
8.7 |
% |
||||||||
|
Diluted earnings (loss) per share: |
||||||||||||||||
|
Continuing operations |
$ |
1.29 |
$ |
1.11 |
||||||||||||
|
Discontinued operations |
(0.01) |
- |
||||||||||||||
|
Net income |
$ |
1.28 |
$ |
1.11 |
||||||||||||
|
Diluted weighted average common shares |
55,778 |
56,393 |
||||||||||||||
|
Other data from continuing operations: |
||||||||||||||||
|
Adjusted EBITDA (3) |
$ |
117,906 |
$ |
104,293 |
||||||||||||
|
(1) |
CBIZ sponsors a deferred compensation plan, under which a CBIZ employee's compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the deferred compensation plan are included in "Operating expenses" ( |
|
(2) |
Included in "Other income, net" for the nine months ended |
|
(3) |
Refer to the financial highlights tables for a reconciliation of Non-GAAP financial measures to the nearest GAAP financial measure, and for additional information as to the usefulness of the Non-GAAP financial measures to shareholders and investors. |
|
|
||||||||||||||||
|
FINANCIAL HIGHLIGHTS (UNAUDITED) |
||||||||||||||||
|
(In thousands) |
||||||||||||||||
|
SELECT SEGMENT DATA |
||||||||||||||||
|
THREE MONTHS ENDED |
NINE MONTHS ENDED |
|||||||||||||||
|
SEPTEMBER 30, |
SEPTEMBER 30, |
|||||||||||||||
|
2019 |
2018 |
2019 |
2018 |
|||||||||||||
|
Revenue |
||||||||||||||||
|
Financial Services |
$ |
153,794 |
$ |
146,145 |
$ |
493,311 |
$ |
478,485 |
||||||||
|
Benefits and Insurance Services |
76,960 |
70,069 |
225,342 |
220,152 |
||||||||||||
|
National Practices |
9,036 |
8,035 |
26,633 |
24,343 |
||||||||||||
|
Total |
$ |
239,790 |
$ |
224,249 |
$ |
745,286 |
$ |
722,980 |
||||||||
|
Gross Margin |
||||||||||||||||
|
Financial Services |
$ |
25,563 |
$ |
21,599 |
$ |
102,464 |
$ |
91,836 |
||||||||
|
Benefits and Insurance Services |
13,570 |
10,670 |
39,506 |
38,455 |
||||||||||||
|
National Practices |
932 |
521 |
2,325 |
1,987 |
||||||||||||
|
Operating expenses - unallocated (1): |
||||||||||||||||
|
Other |
(2,927) |
(4,126) |
(10,095) |
(13,010) |
||||||||||||
|
Deferred compensation |
(6,494) |
(3,022) |
(11,704) |
(4,747) |
||||||||||||
|
Total |
$ |
30,644 |
$ |
25,642 |
$ |
122,496 |
$ |
114,521 |
||||||||
|
(1) |
Represents operating expenses not directly allocated to individual businesses, including stock-based compensation, consolidation and integration charges, and certain advertising expenses. "Operating expenses - unallocated" also include gains or losses attributable to the assets held in a rabbi trust associated with the Company's deferred compensation plan. These gains or losses do not impact "Income from continuing operations before income tax expense" as they are directly offset by the same adjustment to "Other income (expense), net" in the Consolidated Statements of Comprehensive Income. Net gains/losses recognized from adjustments to the fair value of the assets held in the rabbi trust are recorded as compensation expense in "Operating expenses" and "Corporate, general and administrative expense," and offset in "Other income (expense), net". |
|
|
||||||||
|
SELECT CASH FLOW DATA |
||||||||
|
(In thousands) |
||||||||
|
NINE MONTHS ENDED |
||||||||
|
SEPTEMBER 30, |
||||||||
|
2019 |
2018 |
|||||||
|
Net income |
$ |
71,867 |
$ |
62,543 |
||||
|
Adjustments to reconcile net income to net cash provided by |
||||||||
|
Depreciation and amortization expense |
16,610 |
17,528 |
||||||
|
Bad debt expense, net of recoveries |
1,974 |
3,697 |
||||||
|
Adjustments to contingent earnout liability |
322 |
3,290 |
||||||
|
Stock-based compensation expense |
5,258 |
5,358 |
||||||
|
Other noncash adjustments |
1,395 |
(1,989) |
||||||
|
Net income, after adjustments to reconcile net income to net |
97,426 |
90,427 |
||||||
|
Changes in assets and liabilities, net of acquisitions and |
(47,708) |
(26,993) |
||||||
|
Operating cash flows provided by continuing operations |
49,718 |
63,434 |
||||||
|
Operating cash used in discontinued operations |
(304) |
(162) |
||||||
|
Net cash provided by operating activities |
49,414 |
63,272 |
||||||
|
Net cash used in investing activities |
(24,691) |
(39,267) |
||||||
|
Net cash used in financing activities |
(56,473) |
(102,838) |
||||||
|
Net decrease in cash, cash equivalents and restricted cash |
$ |
(31,750) |
$ |
(78,833) |
||||
|
Cash, cash equivalents and restricted cash at beginning of year |
130,554 |
182,262 |
||||||
|
Cash, cash equivalents and restricted cash at end of year |
$ |
98,804 |
$ |
103,429 |
||||
|
Reconciliation of cash, cash equivalents and restricted cash to |
||||||||
|
Cash and cash equivalents |
$ |
2,723 |
$ |
3,493 |
||||
|
Restricted cash |
35,739 |
32,551 |
||||||
|
Cash equivalents included in funds held for clients |
60,342 |
67,385 |
||||||
|
Total cash, cash equivalents and restricted cash |
$ |
98,804 |
$ |
103,429 |
||||
|
|
||||||||
|
SELECT FINANCIAL DATA AND RATIOS |
||||||||
|
(In thousands) |
||||||||
|
SEPTEMBER 30, |
|
|||||||
|
2019 |
2018 |
|||||||
|
Cash and cash equivalents |
$ |
2,723 |
$ |
640 |
||||
|
Restricted cash |
35,739 |
27,481 |
||||||
|
Accounts receivable, net |
260,969 |
207,287 |
||||||
|
Current assets before funds held for clients |
324,451 |
262,249 |
||||||
|
Funds held for clients |
123,448 |
161,289 |
||||||
|
|
658,442 |
637,009 |
||||||
|
Total assets |
$ |
1,397,063 |
$ |
1,183,031 |
||||
|
Current liabilities before client fund obligations |
$ |
186,948 |
$ |
159,241 |
||||
|
Client fund obligations |
123,133 |
162,073 |
||||||
|
Bank debt |
158,744 |
133,974 |
||||||
|
Total liabilities |
$ |
740,767 |
$ |
589,368 |
||||
|
|
$ |
(531,356) |
$ |
(508,530) |
||||
|
Total stockholders' equity |
$ |
656,296 |
$ |
593,663 |
||||
|
Debt to equity |
24.5 |
% |
23.0 |
% |
||||
|
Days sales outstanding (DSO) - continuing operations (1) |
93 |
70 |
||||||
|
Shares outstanding |
54,909 |
55,072 |
||||||
|
Basic weighted average common shares outstanding |
54,215 |
54,561 |
||||||
|
Diluted weighted average common shares outstanding |
55,778 |
56,487 |
||||||
|
(1) |
DSO is provided for continuing operations and represents accounts receivable, net, at the end of the period, divided by trailing twelve month daily revenue. The Company has included DSO data because such data is commonly used as a performance measure by analysts and investors and as a measure of the Company's ability to collect on receivables in a timely manner. DSO should not be regarded as an alternative or replacement to any measurement of performance under GAAP. DSO at |
|
|
||||||||||||||||
|
GAAP RECONCILIATION |
||||||||||||||||
|
Income from Continuing Operations to Non-GAAP Financial Measures (1) |
||||||||||||||||
|
(In thousands) |
||||||||||||||||
|
THREE MONTHS ENDED |
NINE MONTHS ENDED |
|||||||||||||||
|
SEPTEMBER 30, |
SEPTEMBER 30, |
|||||||||||||||
|
2019 |
2018 |
2019 |
2018 |
|||||||||||||
|
Income from continuing operations |
$ |
18,006 |
$ |
13,595 |
$ |
72,185 |
$ |
62,526 |
||||||||
|
Interest expense |
1,521 |
1,614 |
4,509 |
5,211 |
||||||||||||
|
Income tax expense |
6,069 |
3,297 |
25,004 |
19,691 |
||||||||||||
|
Loss (gain) on sale of operations, net |
145 |
- |
(402) |
(663) |
||||||||||||
|
Depreciation |
2,085 |
1,465 |
6,102 |
4,383 |
||||||||||||
|
Amortization |
3,549 |
4,387 |
10,508 |
13,145 |
||||||||||||
|
Adjusted EBITDA |
$ |
31,375 |
$ |
24,358 |
$ |
117,906 |
$ |
104,293 |
||||||||
|
(1) |
CBIZ reports its financial results in accordance with GAAP. This table reconciles Non-GAAP financial measures to the nearest GAAP financial measure, "Income from continuing operations". Adjusted EBITDA is not defined by GAAP and should not be regarded as an alternative or replacement to any measurement of performance or cash flow under GAAP. Adjusted EBITDA is commonly used by the Company, its shareholders and debt holders to evaluate, assess and benchmark the Company's operational results and to provide an additional measure with respect to the Company's ability to meet future debt obligations. |
View original content:http://www.prnewswire.com/news-releases/cbiz-reports-third-quarter-and-nine-month-2019-results-300947769.html
SOURCE



Principal Expands Direct-To-Consumer IRA Offering
Cape Cod Skilled Nursing Facility Receives $28 Million in Financing from Walker & Dunlop
Advisor News
- Affordability on Florida lawmakers’ minds as they return to the state Capitol
- Gen X confident in investment decisions, despite having no plan
- Most Americans optimistic about a financial ‘resolution rebound’ in 2026
- Mitigating recession-based client anxiety
- Terri Kallsen begins board chair role at CFP Board
More Advisor NewsAnnuity News
- Reframing lifetime income as an essential part of retirement planning
- Integrity adds further scale with blockbuster acquisition of AIMCOR
- MetLife Declares First Quarter 2026 Common Stock Dividend
- Using annuities as a legacy tool: The ROP feature
- Jackson Financial Inc. and TPG Inc. Announce Long-Term Strategic Partnership
More Annuity NewsHealth/Employee Benefits News
- In Snohomish County, new year brings changes to health insurance
- Visitor Guard® Unveils 2026 Visitor Insurance Guide for Families, Seniors, and Students Traveling to the US
- UCare CEO salary topped $1M as the health insurer foundered
- Va. Republicans split over extending
Va. Republicans split over extending health care subsidies
- Governor's proposed budget includes fully funding Medicaid and lowering cost of kynect coverage
More Health/Employee Benefits NewsLife Insurance News